Indivior Pharmaceuticals Inc
INDV
Rank in Stocks
#3974
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Share Price
$33.11
Market Cap
$4.13B
Change (1 day)
2.03%
Change (1 year)
35.25%
Country
US
Trade Indivior Pharmaceuticals Inc (INDV)
Category
Healthcare
Earnings for Indivior Pharmaceuticals Inc (INDV)
Earnings in Jun 2026 TTM: $393.00M
According to Indivior Pharmaceuticals Inc latest financial reports the company's current earnings are $393.00M. In 2023 the company made an earning of $-149.00M, a decrease compared to its 2022 earnings that were of $-89.00M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Indivior Pharmaceuticals Inc from 2016 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $393.00M | 2,707.14% |
| 2024 | $14.00M | -109.40% |
| 2023 | $-149.00M | 67.42% |
| 2022 | $-89.00M | -146.84% |
| 2021 | $190.00M | -209.83% |
| 2020 | $-173.00M | -196.11% |
| 2019 | $180.00M | -32.21% |
| 2018 | $265.53M | 84.52% |
| 2017 | $143.91M | 60.35% |
| 2016 | $89.75M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 349.00% |
IN
|
